EXTROVIS GLOBAL PRESENCE

Extrovis Icon
Extrovis Global

RESEARCH & DEVELOPMENT CENTRES

Extrovis Icon

Our research centres operate at the heart of new and differentiated FDFs, APIs and Intermediates. To keep us at the forefront of innovation in pharmaceutical process and intellectual property development, Extrovis concurrently maintains strategy and development teams in India, the EU and US.

Each of our teams champion special areas of expertise, with the full support and collaboration of all our other divisions, particularly by our experienced Development Quality Assurance and Analytical Teams.

Our scientific and technical teams maintain a fascinating mindset of passion, exceptional professionalism, matched by speed, flexibility and a desire for value creation for stakeholders and customers worldwide.

SUPPLY CHAIN HUB

Extrovis Icon

Extrovis EU, based in Hungary, has been set up to function as a global supply chain and customer care hub for the group. We successively build capabilities locally for the following key activities:

  • EU importation, re-testing and release
  • Primary & secondary packaging
  • Late stage customization of various dosage forms for European and other markets
  • Managing regulatory and pharmacovigilance procedures
  • Supply chain co-ordination and customer care

With a collective experience of more than 50 years in Europe, we aim to address the supply chain complexity of European generic pharmaceutical market by reconciling high volume, efficient manufacturing with medium to small volume order demand.

We expect this setup to become fully operational by Q4, 2022.

GMP MANUFACTURING

Extrovis Icon

API GMP Manufacturing

Extrovis’ state-of-the-art manufacturing and R&D facilities, as well as those seamlessly integrated by our partnership network in the EU and India, all comply with the highest international quality standards with accreditations from the USFDA, PMDA, EU and other global regulatory bodies.

Where We Manufacture

APIs: Through strategic manufacturing partnerships in India and Europe.

Regulatory Approvals: API manufacturing sites approved by USFDA, EU Authorities and PMDA Japan.

Extrovis Manufacturing
Extrovis Manufacturing
Extrovis Manufacturing
Extrovis Manufacturing
Extrovis Manufacturing
Extrovis Manufacturing Partner

FDF GMP Manufacturing

We choose GMP manufacturing partners best positioned to produce our diverse range of dosage forms including, vials, cartridges, pre-filled syringes, and bags besides oral solid forms. Most of our contract manufacturing partners have capacity sharing arrangement with Extrovis to ensure long term supply continuity. Extrovis’ Global Quality Management System oversees the entire manufacturing process, while our alliance management function gets involved with our partners every step of the way.